Advent Pharma Ltd. (DSE:ADVENT)
Bangladesh · Delayed Price · Currency is BDT 16.10
0.00 (0.00%)
At close: Aug 13, 2026
Advent Pharma Market Cap
Advent Pharma has a market cap or net worth of 1.5 billion as of August 14, 2026. Its market cap has increased by 8.78% in one year.
Market Cap
1.50B
Enterprise Value
1.58B
Revenue
458.15M
Ranking
n/a
PE Ratio
31.02
Stock Price
16.10
ChartMarket Cap Chart
Since April 12, 2018, Advent Pharma's market cap has decreased from 3.32B to 1.50B, a decrease of -54.84%. That is a compound annual growth rate of -9.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 1.50B | 21.05% |
| Dec 30, 2025 | 1.24B | -20.36% |
| Dec 30, 2024 | 1.56B | -32.93% |
| Dec 28, 2023 | 2.32B | -1.97% |
| Dec 29, 2022 | 2.37B | -0.74% |
| Dec 30, 2021 | 2.38B | 14.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| The IBN SINA Pharmaceutical Industry | 10.03B |
| Navana Pharmaceuticals | 7.45B |
| Orion Pharma | 6.69B |
| Techno Drugs | 5.98B |
| Indo-Bangla Pharmaceuticals | 2.24B |
| Silva Pharmaceuticals | 2.24B |
| Silco Pharmaceuticals | 2.10B |
| Pharma Aids | 1.95B |